國立虎尾科技大學 |

Prevention and Treatment of Atherosclerosis = Improving State-of-the-Art Management and Search for Novel Targets /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Prevention and Treatment of Atherosclerosis / edited by Arnold von Eckardstein, Christoph J. Binder.
其他題名:	Improving State-of-the-Art Management and Search for Novel Targets /
其他作者:	von Eckardstein, Arnold.
面頁冊數:	X, 538 p. 40 illus., 37 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Internal medicine. -
電子資源:	https://doi.org/10.1007/978-3-030-86076-9
ISBN:	9783030860769

Prevention and Treatment of Atherosclerosis = Improving State-of-the-Art Management and Search for Novel Targets /
Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets /[electronic resource] :edited by Arnold von Eckardstein, Christoph J. Binder. - 1st ed. 2022. - X, 538 p. 40 illus., 37 illus. in color.online resource. - Handbook of Experimental Pharmacology,2701865-0325 ;. - Handbook of Experimental Pharmacology,224.

Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.

Open Access

This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. .

ISBN: 9783030860769

Standard No.: 10.1007/978-3-030-86076-9doiSubjects--Topical Terms:

644638
Internal medicine.

LC Class. No.: RC1-1245

Dewey Class. No.: 616

Prevention and Treatment of Atherosclerosis = Improving State-of-the-Art Management and Search for Novel Targets /
LDR:02861nam a22004815i 4500 001 1093687
003 DE-He213
005 20220131170126.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030860769 $9 978-3-030-86076-9
024 7 $a 10.1007/978-3-030-86076-9 $2 doi
035 $a 978-3-030-86076-9
050 4 $a RC1-1245
050 4 $a RC1-1245
072 7 $a MJ $2 bicssc
072 7 $a MJ $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJ $2 thema
072 7 $a MJ $2 thema
082 0 4 $a 616 $2 23
082 0 4 $a 616 $2 23
245 1 0 $a Prevention and Treatment of Atherosclerosis $h [electronic resource] : $b Improving State-of-the-Art Management and Search for Novel Targets / $c edited by Arnold von Eckardstein, Christoph J. Binder.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a X, 538 p. 40 illus., 37 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Handbook of Experimental Pharmacology, $x 1865-0325 ; $v 270
505 0 $a Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.
506 0 $a Open Access
520 $a This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. .
650 0 $a Internal medicine. $3 644638
650 0 $a Pharmacology. $3 583819
650 0 $a Diseases. $3 636013
650 1 4 $a Internal Medicine. $3 668583
700 1 $a von Eckardstein, Arnold. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1254014
700 1 $a Binder, Christoph J. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1401663
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030860752
776 0 8 $i Printed edition: $z 9783030860776
776 0 8 $i Printed edition: $z 9783030860783
830 0 $a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 224 $3 1254015
856 4 0 $u https://doi.org/10.1007/978-3-030-86076-9
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
912 $a ZDB-2-SOB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)